{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:24:20Z","timestamp":1740173060169,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Racial and Ethnic Health Disparities"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Black and Latinx MSM and transgender POC disproportionately experience new HIV diagnoses. Determining effective HIV prevention methods requires the inclusion of these communities in research and thorough post-trial experience evaluations. This study sought to evaluate the experiences of Black and Latinx MSM and transgender POC in HIV prevention research and identify facilitators and barriers to continued trials participation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A survey was developed in partnership with the community engagement team based on emerging themes during research participant check-ins with the team. The survey was built in REDCap and distributed to participants via text message. The survey assessed experiences with the research process time commitments, study responsibilities, compensation, experiences with Truvada\u00ae, characteristics of the research study team and site, barriers to continued study participation, willingness to participate in future studies, and overall satisfaction. All statistical analysis was completed in Stata.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Forty-four participants were enrolled in the study. Most participants (98%) were satisfied with their experiences in HIV prevention research. Job or school schedules were the most frequently cited barrier to study participation while Truvada\u00ae provision and adequate study visit compensation, length, number, and frequency were facilitators. Participants reported that research staff made them feel comfortable when talking about sexual behaviors, alcohol use, mental health, drug use, housing problems, violence in relationships, and legal problems.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Evaluating the experiences of key communities in HIV prevention research can help identify barriers and facilitators to clinical trials engagement and improve the design of future trials.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s40615-022-01340-4","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T15:13:02Z","timestamp":1654787582000},"page":"1542-1548","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HIV Prevention Research Experiences Among Men Who Have Sex With Men and Transgender Persons of Color"],"prefix":"10.1007","volume":"10","author":[{"given":"Aparna","family":"Alankar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamir","family":"Tuten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Travis","family":"Love","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Punsal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shobha","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1703-0500","authenticated-orcid":false,"given":"Amesika N.","family":"Nyaku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,9]]},"reference":[{"key":"1340_CR1","unstructured":"Centers for Disease Control and Prevention. HIV Surveillance Report, 2019. 2021 May. Report No.: vol, 32. Available from: http:\/\/www.cdc.gov\/hiv\/library\/reports\/hiv-surveillance.html"},{"key":"1340_CR2","doi-asserted-by":"publisher","first-page":"e0181702","DOI":"10.1371\/journal.pone.0181702","volume":"12","author":"S Richardson","year":"2017","unstructured":"Richardson S, Seekaew P, Koblin B, Vazquez T, Nandi V, Tieu H-V. Barriers and facilitators of HIV vaccine and prevention study participation among Young Black MSM and transwomen in New York City. PLoS ONE. 2017;12:e0181702.","journal-title":"PLoS ONE"},{"key":"1340_CR3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1177\/0033354918814260","volume":"134","author":"KF Huamani","year":"2019","unstructured":"Huamani KF, Metch B, Broder G, Andrasik M. A Demographic analysis of racial\/ethnic minority enrollment into HVTN preventive early phase HIV vaccine clinical trials conducted in the United States, 2002\u20132016. Public Health Rep. 2019;134:72\u201380.","journal-title":"Public Health Rep"},{"key":"1340_CR4","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1177\/003335490512000509","volume":"120","author":"G Djomand","year":"2005","unstructured":"Djomand G, Katzman J, di Tommaso D, Hudgens MG, Counts GW, Koblin BA, et al. Enrollment of racial\/ethnic minorities in NIAID-funded networks of HIV vaccine trials in the United States, 1988 to 2002. Public Health Rep. 2005;120:543\u20138.","journal-title":"Public Health Rep"},{"key":"1340_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1310\/hct1501-14","volume":"15","author":"JR Castillo-Mancilla","year":"2014","unstructured":"Castillo-Mancilla JR, Cohn SE, Krishnan S, Cespedes M, Floris-Moore M, Schulte G, et al. Minorities Remain underrepresented in HIV\/AIDS research despite access to clinical trials. HIV Clin Trials. 2014;15:14\u201326.","journal-title":"HIV Clin Trials"},{"key":"1340_CR6","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1007\/s10461-018-2114-5","volume":"22","author":"S Tross","year":"2018","unstructured":"Tross S, Pinho V, Lima JE, Ghiroli M, Elkington KS, Strauss DH, et al. Participation in HIV behavioral research: unanticipated benefits and burdens. AIDS Behav. 2018;22:2258\u201366.","journal-title":"AIDS Behav"},{"key":"1340_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/0956462418791946","volume":"30","author":"I Odero","year":"2019","unstructured":"Odero I, Ondeng\u2019e K, Mudhune V, Okola P, Oruko J, Otieno G, et al. Participant satisfaction with clinical trial experience and post-trial transitioning to HIV care in Kenya. Int J STD AIDS. 2019;30:12\u20139.","journal-title":"Int J STD AIDS."},{"key":"1340_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/15284336.2018.1511346","volume":"19","author":"MI Murray","year":"2018","unstructured":"Murray MI, Markowitz M, Frank I, Grant RM, Mayer KH, Hudson KJ, et al. Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: Patient perspectives from the ECLAIR trial. HIV Clin Trials. 2018;19:129\u201338.","journal-title":"HIV Clin Trials"},{"key":"1340_CR9","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1007\/s10461-017-2017-x","volume":"22","author":"D Kerrigan","year":"2018","unstructured":"Kerrigan D, Mantsios A, Grant R, Markowitz M, Defechereux P, La Mar M, et al. Expanding the menu of hiv prevention options: a qualitative study of experiences with long-acting injectable cabotegravir as PrEP in the context of a Phase II trial in the United States. AIDS Behav. 2018;22:3540\u20139.","journal-title":"AIDS Behav"},{"key":"1340_CR10","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377\u201381.","journal-title":"J Biomed Inform"},{"key":"1340_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95: 103208.","journal-title":"J Biomed Inform"},{"key":"1340_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-029852","volume":"10","author":"SL Reisner","year":"2020","unstructured":"Reisner SL, Chaudhry A, Cooney E, Garrison-Desany H, Juarez-Chavez E, Wirtz AL. \u2018It all dials back to safety\u2019: a qualitative study of social and economic vulnerabilities among transgender women participating in HIV research in the USA. BMJ Open. 2020;10: e029852.","journal-title":"BMJ Open"},{"key":"1340_CR13","doi-asserted-by":"publisher","first-page":"E871","DOI":"10.3390\/ijerph17030871","volume":"17","author":"CC Watson","year":"2020","unstructured":"Watson CC, Wilton L, Lucas JP, Bryant L, Victorianne GD, Aradhya K, et al. Development of a black caucus within the HIV prevention trials network (HPTN): representing the perspectives of black men who have sex with men (MSM). Int J Environ Res Public Health. 2020;17:E871.","journal-title":"Int J Environ Res Public Health"},{"key":"1340_CR14","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s11121-013-0371-0","volume":"15","author":"R Yoon","year":"2014","unstructured":"Yoon R, Mooney J, Broder G, Bolton M, Votto T, Davis-Vogel A. Exploring barriers and facilitators to participation of male-to-female transgender persons in preventive HIV vaccine Clinical Trials. Prev Sci. 2014;15:268\u201376.","journal-title":"Prev Sci"},{"key":"1340_CR15","doi-asserted-by":"publisher","first-page":"S243","DOI":"10.1097\/QAI.0000000000001085","volume":"72","author":"RL Siskind","year":"2016","unstructured":"Siskind RL, Andrasik M, Karuna ST, Broder GB, Collins C, Liu A, et al. Engaging transgender people in NIH-funded HIV\/AIDS clinical trials research. J Acquir Immune Defic Syndr. 2016;72:S243\u20137.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1340_CR16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1146\/annurev.publhealth.19.1.173","volume":"19","author":"BA Israel","year":"1998","unstructured":"Israel BA, Schulz AJ, Parker EA, Becker AB. Review of community-based research: assessing partnership approaches to improve public health. Annu Rev Public Health. 1998;19:173\u2013202.","journal-title":"Annu Rev Public Health"},{"key":"1340_CR17","doi-asserted-by":"publisher","first-page":"136","DOI":"10.21106\/ijma.331","volume":"9","author":"AP Alio","year":"2020","unstructured":"Alio AP, Sibley C, Ouedraogo HS, Wallace SE, Wakefield S, Humes DL, et al. House ball community leaders\u2019 perceptions of HIV and HIV vaccine research. Int J MCH AIDS. 2020;9:136\u201345.","journal-title":"Int J MCH AIDS"},{"key":"1340_CR18","first-page":"15","volume":"38","author":"JK Walter","year":"2016","unstructured":"Walter JK, Davis MM. Who\u2019s Willing? Characteristics associated with willingness to participate in clinical research. IRB. 2016;38:15\u20139.","journal-title":"IRB"},{"key":"1340_CR19","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1080\/17441692.2016.1154085","volume":"11","author":"JM Sevelius","year":"2016","unstructured":"Sevelius JM, Keatley J, Calma N, Arnold E. \u201cI am not a man\u201d: Trans-specific barriers and facilitators to PrEP acceptability among transgender women. Glob Public Health. 2016;11:1060\u201375.","journal-title":"Glob Public Health"},{"key":"1340_CR20","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1007\/s10508-017-1049-7","volume":"47","author":"KB Biello","year":"2018","unstructured":"Biello KB, Hosek S, Drucker MT, Belzer M, Mimiaga MJ, Marrow E, et al. Preferences for Injectable PrEP Among Young U.S. Cisgender men and transgender women and men who have sex with men. Arch Sex Behav. 2018;47:2101\u20137.","journal-title":"Arch Sex Behav."},{"key":"1340_CR21","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12874-021-01328-4","volume":"21","author":"A Asquith","year":"2021","unstructured":"Asquith A, Sava L, Harris AB, Radix AE, Pardee DJ, Reisner SL. Patient-centered practices for engaging transgender and gender diverse patients in clinical research studies. BMC Med Res Methodol. 2021;21:202.","journal-title":"BMC Med Res Methodol"},{"key":"1340_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25664","volume":"24","author":"G Mansergh","year":"2021","unstructured":"Mansergh G, Kota KK, Stephenson R, Hirshfield S, Sullivan P. Preference for using a variety of future HIV pre-exposure prophylaxis products among men who have sex with men in three US cities. J Int AIDS Soc. 2021;24: e25664.","journal-title":"J Int AIDS Soc"},{"key":"1340_CR23","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1007\/s10461-019-02703-5","volume":"24","author":"CT Rael","year":"2020","unstructured":"Rael CT, Martinez M, Giguere R, Bockting W, MacCrate C, Mellman W, et al. Transgender women\u2019s concerns and preferences on potential future long-acting biomedical HIV Prevention strategies: the case of injections and implanted medication delivery devices (IMDDs). AIDS Behav. 2020;24:1452\u201362.","journal-title":"AIDS Behav"},{"key":"1340_CR24","doi-asserted-by":"publisher","first-page":"4180","DOI":"10.1007\/s10461-021-03357-y","volume":"25","author":"CT Rael","year":"2021","unstructured":"Rael CT, Lopez-R\u00edos J, McKenna SA, Das D, Dolezal C, Abascal E, et al. Transgender Women\u2019s barriers, facilitators, and preferences on tailored injection delivery strategies to administer long-acting injectable cabotegravir (CAB-LA) for HIV pre-exposure prophylaxis (PrEP). AIDS Behav. 2021;25:4180\u201392.","journal-title":"AIDS Behav"}],"container-title":["Journal of Racial and Ethnic Health Disparities"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-022-01340-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40615-022-01340-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-022-01340-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T14:13:13Z","timestamp":1688566393000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40615-022-01340-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,9]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1340"],"URL":"https:\/\/doi.org\/10.1007\/s40615-022-01340-4","relation":{},"ISSN":["2197-3792","2196-8837"],"issn-type":[{"type":"print","value":"2197-3792"},{"type":"electronic","value":"2196-8837"}],"subject":[],"published":{"date-parts":[[2022,6,9]]},"assertion":[{"value":"25 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Rutgers University Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained from all individual participants and documented.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Informed consent was obtained from all individual participants and documented.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}